PhRMA Foundation Accepting Letters of Intent
Print this Article | Send to Colleague
PhRMA Foundation Accepting Letters of Intent
The PhRMA Foundation seeks to fund research on the use of digital health technologies (DHTs) in underrepresented populations in clinical trials to advance regulatory decision-making.
This program aims to support research to develop, evaluate, and/or implement DHTs for use in diverse populations to improve clinical trial participation.
Submit a letter of intent to compete for one of eight $25,000 planning grants. Those eight candidates will then develop and submit full applications to compete for one of two $500,000 research grants.
Letters of intent are due by Sept. 29 at 12 p.m. ET. Learn more and apply here.
